Avenue Therapeutics

$3.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+1.22%) Today

-$0.03 (-0.90%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ATXI and other stocks, options, and ETFs commission-free!

About ATXI

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY. The listed name for ATXI is Avenue Therapeutics, Inc. Common Stock.

CEO

Lucy Lu

Employees

Headquarters

New York, New York

Founded

2015

Market Cap

55.77M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

131.97K

High Today

$3.39

Low Today

$3.24

Open Price

$3.29

Volume

91.05K

52 Week High

$12.34

52 Week Low

$2.85

Collections

ATXI Earnings

-$0.82

-$0.55

-$0.27

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 29, After Hours